View in EDS HTML Full Text PDF Full Text

Early 3‑day course of remdesivir for the prevention of the progression to severe COVID‑19 in the elderly: A single‑centre, real‑life cohort study.

Saved in:
Bibliographic Details
Title: Early 3‑day course of remdesivir for the prevention of the progression to severe COVID‑19 in the elderly: A single‑centre, real‑life cohort study.
Authors: Georgakopoulou, Vasiliki Epameinondas1,2 (AUTHOR) vaso_georgakopoulou@hotmail.com, Gkoufa, Aikaterini1 (AUTHOR), Makrodimitri, Sotiria1 (AUTHOR), Basoulis, Dimitrios1,2 (AUTHOR), Tsakanikas, Aristeidis1 (AUTHOR), Karamanakos, Georgios1 (AUTHOR), Mastrogianni, Elpida3 (AUTHOR), Voutsinas, Pantazis M.2 (AUTHOR), Spandidos, Demetrios A.4 (AUTHOR), Papageorgiou, Chrysovalantis V.3 (AUTHOR), Gamaletsou, Maria N.2,3 (AUTHOR), Sipsas, Nikolaos V.1,2 (AUTHOR)
Source: Experimental & Therapeutic Medicine. Oct2023, Vol. 26 Issue 4, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17920981
DOI:10.3892/etm.2023.12161